1. Strategies for enhancing tumor immunogenicity (or how transform a tumor cell in a Frankenstenian APC);Cavallo,1999
2. The Frankenstein Syndrome;Rollin,1995
3. T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years;Blaese;Science,1995
4. Human gene therapy;Anderson;Science,1992
5. Recombinant adenovirus expressing wild-type p53 is antiangiogenic: a proposed mechanism for bystander effect;Nishizaki;Clin. Cancer Res.,1999